The average price target for Caris Life Sciences, Inc. is 38.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $28.00. The average price target represents 43.50% Increase from the current price of $26.76.